05 / 25 / 2022
Comprehensive Analysis of KRAS Variants in Patients (Pts) with Pancreatic Cancer
Molecular profiling in pancreatic adenocarcinoma (PDAC) has gained traction and we recently demonstrated that targeting actionable alterations can improve patient (pt) outcomes using the Perthera Platform’s real-world evidence database.